# Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition

> **NCT05729555** · PHASE1 · UNKNOWN · sponsor: **Overseas Pharmaceuticals, Ltd.** · enrollment: 16 (estimated)

## Conditions studied

- Pain
- Insomnia

## Interventions

- **DRUG:** Compound ibuprofen polyrelease tablets
- **DRUG:** reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)

## Key facts

- **NCT ID:** NCT05729555
- **Lead sponsor:** Overseas Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-03
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2023-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05729555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05729555, "Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT05729555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
